20/03/2006 (Agence Europe) - During a meeting in Brussels on 13 March, representatives of the European Commission, the European Medicines Agency (EMEA) and the US Food and Drug Administration (FDA) took stock of transatlantic cooperation in the medicines sector. Participants judged that the existing agreements between EMEA and FDA have been a success when it comes to information exchange, parallel procedures for the use of medicines and pharmacovigilance. The parties agreed to step up...